Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer is a research paper published in Cancer Letters (2020). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA200787
National Cancer Institute
Cancer Prevention and Research Institute of Texas
FWCI
1.10
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals